CEO Interview, Chordia Therapeutics

‘We will be a pharmaceutical company by 2030’
Interview with Miyake, CEO of Chordia Therapeutics, which listed on the Growth Market of the Tokyo Stock Exchange this year. From spin-out from Takeda to listing.
https://miyata-bio.net/column/0000391/